748 related articles for article (PubMed ID: 32103756)
1. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome.
Paoli A; Mancin L; Giacona MC; Bianco A; Caprio M
J Transl Med; 2020 Feb; 18(1):104. PubMed ID: 32103756
[TBL] [Abstract][Full Text] [Related]
2. Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome.
Li C; Xing C; Zhang J; Zhao H; Shi W; He B
J Transl Med; 2021 Apr; 19(1):148. PubMed ID: 33849562
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
4. Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome.
Cincione RI; Losavio F; Ciolli F; Valenzano A; Cibelli G; Messina G; Polito R
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886216
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the portfolio low-carbohydrate diet and the ketogenic diet in overweight and obese women with polycystic ovary syndrome: study protocol for a randomized controlled trial.
Najafabadi MS; Moludi J; Salimi Y; Saber A
Trials; 2023 Aug; 24(1):509. PubMed ID: 37559131
[TBL] [Abstract][Full Text] [Related]
6. Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome.
Cincione IR; Graziadio C; Marino F; Vetrani C; Losavio F; Savastano S; Colao A; Laudisio D
J Endocrinol Invest; 2023 Apr; 46(4):769-777. PubMed ID: 36401759
[TBL] [Abstract][Full Text] [Related]
7. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
[TBL] [Abstract][Full Text] [Related]
9. Serum neudesin levels in patients with polycystic ovary syndrome.
Yilmaz Yasar H; Demirpence M; Colak A; Zeytinli M; Yasar E; Taylan A
Ginekol Pol; 2022; 93(7):525-530. PubMed ID: 34263912
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
11. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
14. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
16. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
17. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
18. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
19. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
20. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
